# Single-Dose Study of MT203

> **NCT02354599** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 32 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** MT203 80 mg or matching Placebo
- **DRUG:** MT203 150mg or matching Placebo
- **DRUG:** MT203 300 mg or matching placebo

## Key facts

- **NCT ID:** NCT02354599
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2016-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02354599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02354599, "Single-Dose Study of MT203". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02354599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*